Interactions of clobazam with conventional antiepileptics in children

Journal of Child Neurology

Volumn 12, Issue 3, 1997, Pages 208-213

  Theis, Jochen G W ^a   Koren, Gideon ^a   Daneman, Richard ^a   Sherwin, Allan L ^c   Menzano, Enrique ^a,b,d   Cortez, Miguel ^a,b   Hwang, Paul ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Children's Hospital   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; ATAXIA; BEHAVIOR DISORDER; CHILD; COGNITIVE DEFECT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; HUMAN; INFANT; INSOMNIA; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOMNOLENCE;

EID: 0030937177     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200311     Document Type: Article

References (30)

1. Sheth RD, Ronen GM, Goulden KJ, et al: Clobazam for intractable pediatric epilepsy. J Child Neurol 1995;10:205-208.
2. Canadian Clobazam Cooperative Group: Clobazam in treatment of refractory epilepsy: The Canadian experience. A retrospective study. Epilepsia 1991;32:407-416.
3. Buchanan N: Clobazam in the treatment of epilepsy: Prospective follow-up to 8 years. J R Soc Med 1993;86:378-380.
4. Keene DL, Whiting S, Humphreys P: Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood. Can J Neurol Sci 1990;17:317-319.
5. Patsalos PN, Duncan JS: Antiepileptic drugs. A review of clinically significant drug interactions. Drug Saf 1993;9:156-184.
6. Remy C: Clobazam in the treatment of epilepsy: A review of the literature. Epilepsia 1994;35(Suppl 5):S88-S91.
7. Zifkin B, Sherwin A, Andermann F: Phenytoin toxicity due to interaction with clobazam. Neurology 1991;41:313-314.
8. Cocks A, Critchley EMR, Hayward HD, Thomas D: The effect of clobazam on the blood levels of sodium valproate, in Hindmarch I, Stonier PD, Trimble MR (eds): Clobazam: Human Psychopharmacology and Clinical Applications (International Congress and Symposium Series, Number 74). London, The Royal Society of Medicine, 1985, pp 155-157.
9. MacLeod SM: Clinical pharmacokinetics: A pediatric overview, in Radde CI, MacLeod SM (eds): Pediatric Pharmacology and Therapeutics. 2nd ed. St Louis, Mosby, 1993 pp 157-161.
10. Heazlewood RL, Lemass RWJ: Simple high performance liquid chromatographic assay for the routine monitoring of clonazepam in plasma. J Chromatogr 1984;336:229-233.
11. Guberman A, Conture M, Blaschuk K, Sherwin A: Add on trial of clobazam in intractable adult epilepsy with plasma level correlations. Can J Neurol Sci 1990;17:311-316.
12. Soldin SJ, Hill JG: The therapeutic monitoring of anticonvulsant drugs in a 650-bed children's hospital, in Hawk GL (ed): Biological/Biomedical Application of Liquid Chromatography. New York, Marcel Dekker, 1979.
13. Patsalos PN, Duncan JS: Antiepileptic drugs. A review of clinically significant drug interactions. Drug Saf 1993;9:156-184.
14. Vakil SD, Critchley EMR, Cocks A, Hayward HW: The effect of clobazam on blood vessels of phenobarbitone, phenytoin and carbamazepine (preliminary report), in Hindmarch I, Stonier PD (eds): Clobazam (International Congress and Symposium Series, Number 43). London, The Royal Society of Medicine, 1981, pp 165-167.
15. Wilson A, Dellaportas CI, Clifford Rose F: Low dose clobazam as adjunctive treatment in chronic epilepsy, in Hindmarch I, Stonier PD, Trimble MR (eds): Clobazam: Human Psychopharmacology and Clinical Applications (International Congress and Symposium Series, Number 74). London, The Royal Society of Medicine, 1985, pp 173-178.
16. Allen JW, Oxley J, Robertson MM, et al: Clobazam as adjunctive treatment in refractory epilepsy. BMJ 1983;286:1246-1247.
17. Sennoune S, Mesdjian E, Bonneton J, et al: Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy. Ther Drug Monit 1992;14:269-274.
18. Muñoz JJ, De Salamanca RE, Diaz-Obregõn C, Timoneda FL: The effect of clobazam on the steady state plasma concentrations of carbamazepine and its metabolites. Br J Clin Pharmacol 1990;29:763-765.
19. Goggin T, Callaghan N: Blood levels of clobazam and its metabolites and therapeutic effect, in Hindmarch I, Stonier PD, Trimble MR (eds): Clobazam: Human Psychopharmacology and Clinical Applications (International Congress and Symposium Series, Number 74). London, The Royal Society of Medicine, 1985, pp 149-153.
20. Franceschi M, Ferini-Strambi L, Mastrangelo M, Smirme S: Clobazam in drug resistant and alcoholic withdrawal seizures. Clin Trials J 1983;20:119-125.
21. Wolf P, Beck Mannagetta G, Meencke J, et al: Erfahrungen mit der Anwendung von clobazam (Frisium) als Antiepileptikum, in Remschmidt H, Rentz R, Jungmann J (eds.): Epilepsie 1980. Psychosoziale Aspekte, Posttraumatische Epilepsien, Medikamentöse Behandlung, Diagnostische Methoden. Stuttgart, Georg Thieme Verlag, 1981, pp 164-171.
22. Sobaniec W: Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children. Mater Med Pol 1992;24:115-119.
23. Schmidt D, Rohde M, Wolf P, Roeder-Wanner U: Clobazam for refractory focal epilepsy. A controlled trial. Arch Neurol 1986;43:824-826.
24. Bun H, Monjanel-Mouterde S, Noel F, et al: Effects of age and antiepileptic drugs on plasma levels and kinetics of Clobazam and N-desmethylclobazam. Pharm Toxicol 1990;67:136-140.
25. Bun H, Coassolo P, Gouezo F, et al: Plasma levels and pharmacokinetics of clobazam and N-desmethylclobazam in epileptic patients, in Hindmarch I, Stonier PD, Trimble MR (eds): Clobazam: Human Psychopharmacology and Clinical Applications (International Congress and Symposium Series, Number 74). London, The Royal Society of Medicine, 1985, pp 159-165.
26. Jawad S, Richens A, Oxley J: Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients. Br J Clin Pharmacol 1984;18:873-877.
27. Levy RH, Lane EA, Guyot M, et al: Analysis of parent drug-metabolite relationship in the presence of an inducer, application to the carbamazepine-clobazam interaction in normal man. Drug Metab Dispos 1983;11:286-292.
28. Cano JP, Bun H, Iliadis A, et al: Influence of antiepileptic drugs on plasma levels of clobazam and desmethylclobazam: Application of research on relations between doses, plasma levels and clinical efficacy, in Hindmarch I, Stonier PD (eds). Clobazam (International Congress and Symposium Series, Number 43). London, The Royal Society of Medicine, 1981, pp 169-174.
29. Spino M, Rasymas A, Radde IC: Dosing considerations and therapeutic drug monitoring, in Radde CI, MacLeod SM (eds). Pediatric Pharmacology and Therapeutics, 2nd ed. St Louis, Mosby, 1993, pp 169-183.
30. Fielding S, Hoffman I: Pharmacology of antianxiolytic drugs with special reference to clobazam. Br J Clin Pharmacol 1979;7 (Suppl):7S-15S.